Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

LEO Innovation Lab - LEO Ventures A/SLEO Innovation Lab - LEO Ventures A/S
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
LEO Innovation Lab - LEO Ventures A/S

LEO Innovation Lab - LEO Ventures A/S

LEO Innovation LAB Silkegade 8 Copenhagen, København K 1113, DK

Last Update: 09/06/2026

View Profile
753/1000Fair

LEO Innovation Lab is an independent unit, established by LEO Pharma as part of a long-term strategic decision to focus on patient needs. We nurture companies to lead the digital health revolution with the single goal of improving the quality of life for people living ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:51-200
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 04/04/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
779/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:17,740
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
LEO Innovation Lab - LEO Ventures A/S

LEO Innovation Lab - LEO Ventures A/S

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for LEO Innovation Lab - LEO Ventures A/S in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - LEO Innovation Lab - LEO Ventures A/S (X = Date, Y = Severity)

LEO Innovation Lab - LEO Ventures A/S cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
LEO Innovation Lab - LEO Ventures A/S

LEO Innovation Lab - LEO Ventures A/S

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between LEO Innovation Lab - LEO Ventures A/S company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between LEO Innovation Lab - LEO Ventures A/S and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between LEO Innovation Lab - LEO Ventures A/S and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - LEO Innovation Lab - LEO Ventures A/S or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - LEO Innovation Lab - LEO Ventures A/S or MANKIND PHARMA LTD ?
Between LEO Innovation Lab - LEO Ventures A/S and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between LEO Innovation Lab - LEO Ventures A/S and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-19961
SUMMARY

A vulnerability was detected in Edimax EW-7478APC 1.04. Affected is the function formWlSiteSurvey of the file /goform/formWlSiteSurvey. Performing a manipulation of the argument selSSID results in buffer overflow. The attack is possible to be carried out remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19960
SUMMARY

A security vulnerability has been detected in Edimax EW-7478APC 1.04. This impacts the function formWlbasic of the file /goform/formWlbasic. Such manipulation of the argument rootAPmac leads to command injection. The attack can be executed remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 7.4)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 7.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:L/SI:L/SA:L/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.7
EXPLOITABILITY
3.1
CVE-2026-19959
SUMMARY

A weakness has been identified in Edimax EW-7478APC 1.04. This affects the function formWanTcpipSetup of the file /goform/formWanTcpipSetup. This manipulation of the argument pppUserName causes stack-based buffer overflow. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19958
SUMMARY

A security flaw has been discovered in iatsiuk pptr-mcp up to 0.2.7. The impacted element is the function executeCode of the file src/vm-executor.ts of the component execute Tool. The manipulation results in code injection. The attack may be launched remotely. The exploit has been released to the public and may be used for attacks. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-19957
SUMMARY

A vulnerability was identified in graphlit graphlit-mcp-server 1.0.1. This affects the function fetch of the file src/tools.ts of the component ssrf-test Endpoint. Such manipulation of the argument url leads to server-side request forgery. The attack may be launched remotely. The exploit is publicly available and might be used. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8